Back to MS MSD Partners, L.P.
WEWEK
Showing 0 of 19 quarters
Position history for MSMSD Partners, L.P.'s holdings in ZIOPHARM ONCOLOGY INC
As of its Q4 2023 13F, MSD Partners held 15,151,516 shares of WEK (Ziopharm Oncology), worth $1.1M. MSD Partners' 13F filings listed WEK from Q3 2019 to Q4 2023, 18 quarterly filings. WEK was 0.1% of MSD Partners' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.